FdaApplication
BLA 761358
Identifiers
- fda_app_no: BLA761358
Properties
| Property | Value |
|---|---|
| applicant_name | CELLTRION, Inc. |
| application_type | BLA |
| approval_date | 2023-10-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYMFENTRA | INFLIXIMAB-DYYB | 120MG/ML | Injection |
| ZYMFENTRA | — | 120MG/ML | Injection |
2 products